Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sientra's Pre-Tax Income for the
three
months ended in Sep. 2023 was $-14.77 Mil. Sientra's Revenue for the
three
months ended in Sep. 2023 was $19.54 Mil. Therefore, Sientra's pretax margin for the quarter that ended in Sep. 2023 was -75.59%.
The historical rank and industry rank for Sientra's Pretax Margin % or its related term are showing as below:
SIENQ'
s Pretax Margin % Range Over the Past 10 Years
Min: -193.43 Med: -114.75 Max: -12.99
Current: -65.68
SIENQ's Pretax Margin % is ranked worse than 71.66% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 0.05
vs SIENQ: -65.68
Sientra Pretax Margin % Historical Data
The historical data trend for Sientra's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sientra's Pretax Margin %
For the Medical Devices subindustry, Sientra's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sientra's Pretax Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sientra's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sientra's Pretax Margin % falls into.
Sientra Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Sientra's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sientra (OTCPK:SIENQ) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sientra Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Sientra's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SIENQ has been successfully added to your 